Annual EBITDA
$473.73M$127.14M+36.68%
Summary
- Current Value
- As of today, GMED annual EBITDA is $473.73M, up +36.68% on
- Historical Performance
- GMED annual EBITDA is up +78.95% over the past 3 years, and up +106.43% over the past 5 years
- All-Time High Comparison
- GMED annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- GMED annual EBITDA is +55.57% above its 3-year low of $304.50M reached on an earlier date
- Sector Comparison
- GMED annual EBITDA is higher than 91.92% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $473.73M | +36.7% | +79.0% | +106.4% | +386.9% | |
| Quarterly EBITDA | $205.81M | +77.5% | +168.6% | +204.6% | +658.1% | |
| TTM EBITDA | $724.86M | +65.4% | +139.2% | +279.0% | +2570.1% | |
| Price | $88.22 | +0.3% | +14.7% | +39.2% | – | |
| PE Ratio | 28.51 | -75.9% | -31.3% | -54.9% | – | |
| Annual Revenue | $2.52B | +60.6% | +162.9% | +220.8% | +890.5% | |
| Annual EPS | $0.75 | -30.3% | -48.1% | -50.9% | +38.3% | |
| $219.70M | +8.8% | +12.8% | +24.3% | +162.2% | ||
| Annual Net Income | $102.98M | -16.2% | -31.0% | -33.6% | +97.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $473.73M | at high | |
| 5Y | $473.73M | at high | |
| All | $473.73M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $304.50M | N/A | +55.6% |
| 5Y | $178.35M | N/A | +165.6% |
| All | $97.30M | +386.9% |
EBITDA History
FAQ
What is the current annual EBITDA of GMED?
As of today, GMED annual EBITDA is $473.73M
What is 1-year change in GMED annual EBITDA?
GMED annual EBITDA is up +36.68% year-over-year
What is 3-year change in GMED annual EBITDA?
GMED annual EBITDA is up +78.95% over the past 3 years
How far is GMED annual EBITDA from its all-time high?
GMED annual EBITDA is currently at its all-time high
How does GMED annual EBITDA rank versus sector peers?
GMED annual EBITDA is higher than 91.92% of companies in Healthcare sector
When is GMED next annual earnings release?
The next annual earnings release for GMED is on
Quarterly EBITDA
$205.81M$8.95M+4.55%
Summary
- Current Value
- As of today, GMED quarterly EBITDA is $205.81M, up +4.55% on
- Historical Performance
- GMED quarterly EBITDA is up +77.51% year-over-year, and up +168.59% over the past 3 years
- All-Time High Comparison
- GMED quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- GMED quarterly EBITDA is +171.26% above its 3-year low of $75.87M reached on
- Sector Comparison
- GMED quarterly EBITDA is higher than 92.75% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $205.81M | +4.5% | +77.5% | +168.6% | +204.6% | |
| Annual EBITDA | $473.73M | – | +36.7% | +79.0% | +106.4% | |
| TTM EBITDA | $724.86M | +14.2% | +65.4% | +139.2% | +279.0% | |
| Price | $88.22 | +43.0% | +0.3% | +14.7% | +39.2% | |
| PE Ratio | 28.51 | +43.0% | -75.9% | -31.3% | -54.9% | |
| Quarterly Revenue | $769.05M | +3.2% | +22.9% | +202.6% | +255.9% | |
| Quarterly EPS | $0.88 | -40.9% | +134.1% | +87.9% | +99.7% | |
| $134.69M | +6.7% | +174.9% | +128.1% | +162.7% | ||
| Quarterly Net Income | $118.97M | -41.4% | +129.5% | +150.8% | +169.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $205.81M | at high | |
| 3Y | $205.81M | at high | |
| 5Y | $205.81M | at high | |
| All | $205.81M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $157.90M | N/A | +30.4% |
| 3Y | $75.87M | +171.3% | |
| 5Y | $65.55M | +214.0% | |
| All | $14.19M | +1350.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of GMED?
As of today, GMED quarterly EBITDA is $205.81M
What is GMED quarterly EBITDA most recent change?
GMED quarterly EBITDA was up +4.55% on September 30, 2025
What is 1-year change in GMED quarterly EBITDA?
GMED quarterly EBITDA is up +77.51% year-over-year
How far is GMED quarterly EBITDA from its all-time high?
GMED quarterly EBITDA is currently at its all-time high
How does GMED quarterly EBITDA rank versus sector peers?
GMED quarterly EBITDA is higher than 92.75% of companies in Healthcare sector
When is GMED next earnings release?
The next earnings release for GMED is on
TTM EBITDA
$724.86M$89.87M+14.15%
Summary
- Current Value
- As of today, GMED TTM EBITDA is $724.86M, up +14.15% on
- Historical Performance
- GMED TTM EBITDA is up +65.43% year-over-year, and up +139.23% over the past 3 years
- All-Time High Comparison
- GMED TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- GMED TTM EBITDA is +137.93% above its 3-year low of $304.66M reached on an earlier date
- Sector Comparison
- GMED TTM EBITDA is higher than 92.56% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $724.86M | +14.2% | +65.4% | +139.2% | +279.0% | |
| Annual EBITDA | $473.73M | – | +36.7% | +79.0% | +106.4% | |
| Quarterly EBITDA | $205.81M | +4.5% | +77.5% | +168.6% | +204.6% | |
| Price | $88.22 | +43.0% | +0.3% | +14.7% | +39.2% | |
| PE Ratio | 28.51 | +43.0% | -75.9% | -31.3% | -54.9% | |
| TTM Revenue | $2.77B | +5.5% | +11.8% | +177.4% | +261.0% | |
| TTM EPS | $3.09 | +19.4% | +366.8% | +105.0% | +235.4% | |
| $448.80M | +23.6% | +147.7% | +91.1% | +242.0% | ||
| TTM Net Income | $423.78M | +18.8% | +363.1% | +173.0% | +346.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $724.86M | at high | |
| 3Y | $724.86M | at high | |
| 5Y | $724.86M | at high | |
| All | $724.86M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $498.94M | N/A | +45.3% |
| 3Y | $304.66M | N/A | +137.9% |
| 5Y | $202.75M | N/A | +257.5% |
| All | $27.15M | +2570.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of GMED?
As of today, GMED TTM EBITDA is $724.86M
What is GMED TTM EBITDA most recent change?
GMED TTM EBITDA was up +14.15% on September 30, 2025
What is 1-year change in GMED TTM EBITDA?
GMED TTM EBITDA is up +65.43% year-over-year
How far is GMED TTM EBITDA from its all-time high?
GMED TTM EBITDA is currently at its all-time high
How does GMED TTM EBITDA rank versus sector peers?
GMED TTM EBITDA is higher than 92.56% of companies in Healthcare sector
When is GMED next earnings release?
The next earnings release for GMED is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- GMED Official Website www.globusmedical.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1237831/000123783125000031/0001237831-25-000031-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1237831/000156276225000026/0001562762-25-000026-index.htm
- GMED Profile on Yahoo Finance finance.yahoo.com/quote/GMED
- GMED Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gmed